What is Automated External Defibrillator?
business consulting services
Moreover, the rising prevalence of lifestyle disorders such as hypertension and diabetes is also considered as a key factor in the growing number of cases of cardiac arrests. As per the data provided by the Centers for Disease Control and Prevention (2021), in 2018, near about 116 million people in the United States suffered from hypertension. Additionally, the data stated in the National Diabetes Report of the CDC, in 2020, 34.2 million Americans had diabetes and near about 88 million American adults exhibited prediabetic levels.
Automated External Defibrillator Market Dynamics
Both hypertension and diabetes are considered to be one of the key risk factors for the development of atrial fibrillation in patients and in turn make them susceptible to increased chances of stroke. Strokes are considered as a medical emergency and urgent treatment is essential because the sooner a person receives treatment for a stroke, the less damage is likely to happen and an AED plays as extremely crucial part in the administration of treatment.
Therefore, the presence of large patient population suffering from hypertension and diabetes correlates to the presence of a high patient population suffering from heart diseases such as strokes and cardiac arrests which would indicate the growing need for automated external defibrillators, thereby resulting in increase in product demand supporting the growth of the United States automated external defibrillators market as well as the overall North America automated external defibrillators market during the forecast period.
Coupled with the factors mentioned above, the increasing interest of product manufacturers in the region also helps in boosting the regional product demand. For instance, in December 2019, Stryker launched the company's newest defibrillation solution, the LIFEPAK® CR2 defibrillator with LIFELINKcentral™ AED program manager, in the United States. Such measures help in gaining the market share for the manufacturers as well as benefit end users in terms of better product pricing from the competition standpoint, thereby driving the North America AED market forward during the forecast period.
Automated External Defibrillators Market Companies
Some of the key market players operating in the automated external defibrillators market includes Koninklijke Philips N.V., Stryker, NIHON KOHDEN CORPORATION, SCHILLER, ZOLL Medical Corporation, Kestra Medical Technologies, Inc., BPL Medical Technologies, MEDIANA Co., Ltd, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Meditech Equipment Co.,Ltd, HEARTHERO, Metrax GmbH, Progetti Srl, Bexen Cardio, Trivitron Healthcare, Amiitalia, US DEFIB MEDICAL TECHNOLOGIES, LLC, Instramed Indústria Médico Hospitalar Ltda., Axion Ltd, CardiAid and others.